Sfoglia per Autore SACRIPANTI, GINEVRA
Assay of endogenous 3,5-diiodo-L-thyronine (3,5-T2) and 3,3’-diiodo-L-thyronine (3,3’-T2) in human serum.
2017-01-01 Lorenzini, Leonardo; Nguyen, NHAT MINH; Sacripanti, Ginevra; Serni, Enrico; Saba, Alessandro; Ghelardoni, Sandra; Zucchi, Riccardo
Effects of 3,5-diiodo-L-thyronine on the cardiac tissue
2017-01-01 Nguyen, NHAT MINH; Lorenzini, Leonardo; Sacripanti, Ginevra; Frascarelli, Sabina; Saba, Alessandro; Zucchi, Riccardo; Ghelardoni, Sandra
Effects of 3-iodothyronamine (T1AM) on signaling pathways involved in synaptic plasticity and neuroprotection.
2017-01-01 Sacripanti, Ginevra; Pia Fogliaro, Maria; Giannini, Giulia; Lorenzini, Leonardo; Zucchi, Riccardo; Ghelardoni, Sandra
3,5-diiodo-L-thyronine increases glucose consumption in cardiomyoblasts without affecting the contractile performance in rat heart
2018-01-01 Sacripanti, Ginevra; Nguyen, Nhat Minh; Lorenzini, Leonardo; Frascarelli, Sabina; Saba, Alessandro; Zucchi, Riccardo; Ghelardoni, Sandra
Effects of 3-iodothyronamine (T1AM) on long term potentiation (LTP) postsynaptic signaling cascade
2018-01-01 Sacripanti, Ginevra; Bandini, Lavinia; Pia Fogliaro, Maria; Giannini, Giulia; Lorenzini, Leonardo; Zucchi, Riccardo; Ghelardoni, Sandra
3-iodothyronamine (T1AM) induces changes on glutamatergic postsynaptic signaling pathway
2019-01-01 Bandini, Lavinia; Sacripanti, Ginevra; Figuccia Matteo, Emanuele; Verlotta, Sara; Zucchi, Riccardo; Ghelardoni, Sandra
Assay of endogenous 3,5-diiodo-L-thyronine (3,5-T2) and 3,3’-diiodo-L-thyronine (3,3’-T2) in human serum: a feasibility study
2019-01-01 Lorenzini, Leonardo; Nguyen, Nhat Minh; Sacripanti, Ginevra; Serni, Enrico; Borso', Marco; Saponaro, Federica; Cecchi, Elena; Simoncini, Tommaso; Ghelardoni, Sandra; Zucchi, Riccardo; Saba, Alessandro
3-Iodothyronamine and 3,5,3’-triiodo-L-thyronine reduce SIRT1 protein expression in HepG2 cell line.
2020-01-01 Sacripanti, Ginevra; Lorenzini, Leonardo; Bandini, Lavinia; Frascarelli, Sabina; Zucchi, Riccardo; Ghelardoni, Sandra
Exogenous 3-Iodothyronamine (T1AM) Can Affect Phosphorylation of Proteins Involved on Signal Transduction Pathways in In Vitro Models of Brain Cell Lines, but These Effects Are Not Strengthened by Its Catabolite, 3-Iodothyroacetic Acid (TA1)
2022-01-01 Bandini, Lavinia; Sacripanti, Ginevra; Borsò, Marco; Tartaria, Maria; Fogliaro, Maria Pia; Giannini, Giulia; Carnicelli, Vittoria; Figuccia, Matteo Emanuele; Verlotta, Sara; De Antoni, Fiammetta; Zucchi, Riccardo; Ghelardoni, Sandra
Titolo | Data di pubblicazione | Autore(i) | File |
---|---|---|---|
Assay of endogenous 3,5-diiodo-L-thyronine (3,5-T2) and 3,3’-diiodo-L-thyronine (3,3’-T2) in human serum. | 1-gen-2017 | Lorenzini, Leonardo; Nguyen, NHAT MINH; Sacripanti, Ginevra; Serni, Enrico; Saba, Alessandro; Ghelardoni, Sandra; Zucchi, Riccardo | |
Effects of 3,5-diiodo-L-thyronine on the cardiac tissue | 1-gen-2017 | Nguyen, NHAT MINH; Lorenzini, Leonardo; Sacripanti, Ginevra; Frascarelli, Sabina; Saba, Alessandro; Zucchi, Riccardo; Ghelardoni, Sandra | |
Effects of 3-iodothyronamine (T1AM) on signaling pathways involved in synaptic plasticity and neuroprotection. | 1-gen-2017 | Sacripanti, Ginevra; Pia Fogliaro, Maria; Giannini, Giulia; Lorenzini, Leonardo; Zucchi, Riccardo; Ghelardoni, Sandra | |
3,5-diiodo-L-thyronine increases glucose consumption in cardiomyoblasts without affecting the contractile performance in rat heart | 1-gen-2018 | Sacripanti, Ginevra; Nguyen, Nhat Minh; Lorenzini, Leonardo; Frascarelli, Sabina; Saba, Alessandro; Zucchi, Riccardo; Ghelardoni, Sandra | |
Effects of 3-iodothyronamine (T1AM) on long term potentiation (LTP) postsynaptic signaling cascade | 1-gen-2018 | Sacripanti, Ginevra; Bandini, Lavinia; Pia Fogliaro, Maria; Giannini, Giulia; Lorenzini, Leonardo; Zucchi, Riccardo; Ghelardoni, Sandra | |
3-iodothyronamine (T1AM) induces changes on glutamatergic postsynaptic signaling pathway | 1-gen-2019 | Bandini, Lavinia; Sacripanti, Ginevra; Figuccia Matteo, Emanuele; Verlotta, Sara; Zucchi, Riccardo; Ghelardoni, Sandra | |
Assay of endogenous 3,5-diiodo-L-thyronine (3,5-T2) and 3,3’-diiodo-L-thyronine (3,3’-T2) in human serum: a feasibility study | 1-gen-2019 | Lorenzini, Leonardo; Nguyen, Nhat Minh; Sacripanti, Ginevra; Serni, Enrico; Borso', Marco; Saponaro, Federica; Cecchi, Elena; Simoncini, Tommaso; Ghelardoni, Sandra; Zucchi, Riccardo; Saba, Alessandro | |
3-Iodothyronamine and 3,5,3’-triiodo-L-thyronine reduce SIRT1 protein expression in HepG2 cell line. | 1-gen-2020 | Sacripanti, Ginevra; Lorenzini, Leonardo; Bandini, Lavinia; Frascarelli, Sabina; Zucchi, Riccardo; Ghelardoni, Sandra | |
Exogenous 3-Iodothyronamine (T1AM) Can Affect Phosphorylation of Proteins Involved on Signal Transduction Pathways in In Vitro Models of Brain Cell Lines, but These Effects Are Not Strengthened by Its Catabolite, 3-Iodothyroacetic Acid (TA1) | 1-gen-2022 | Bandini, Lavinia; Sacripanti, Ginevra; Borsò, Marco; Tartaria, Maria; Fogliaro, Maria Pia; Giannini, Giulia; Carnicelli, Vittoria; Figuccia, Matteo Emanuele; Verlotta, Sara; De Antoni, Fiammetta; Zucchi, Riccardo; Ghelardoni, Sandra |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile